Clinical Trials Browser

Observational × Oxaliplatin × Clear all

NCT02394834 2025-05-09

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06718257 2025-02-06

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Gastrointestinal

Cholangiocarcinoma

NCT04679597 2024-10-17

Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure

Gastrointestinal

Rectal Neoplasms

NCT06504875 2024-07-17

Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer

Not yet recruiting

Gastrointestinal

Rectal Neoplasms

NCT06194981 2024-01-12

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastrointestinal

Stomach Neoplasms

NCT03451370 2023-11-29

COBRA

Gastrointestinal

Elderly Metastatic Colorectal Cancer Patients

NCT06068023 2023-10-05

ADAPTA

Ampullary Adenocarcinoma

NCT05176964 2023-09-25

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

Gastrointestinal

Rectal Neoplasms

NCT05489692 2022-08-10

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

Gastrointestinal

Cholangiocarcinoma

NCT02860234 2021-07-23

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Gastrointestinal

Rectal Neoplasms

NCT04913896 2021-06-04

CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy

Gastrointestinal

Stomach Neoplasms

NCT02135887 2020-12-22

MB-6

Gastrointestinal

Neutropenia, Colorectal Neoplasms

NCT04405206 2020-10-14

BJCC-R01

Gastrointestinal

Rectal Neoplasms

NCT02970526 2020-09-16

PREVOX

Gastrointestinal

Colorectal Cancer Survivors

NCT04122885 2019-10-10

IMMUNOPAC

Peritoneal Cancer

NCT03923036 2019-04-22

AVOCETTE

Gastrointestinal

Colorectal Cancer Metastatic

NCT03668418 2018-09-12

xenoZ

Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03532711 2018-05-22

Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer

Gastrointestinal

Colorectal Neoplasms

NCT03237507 2017-08-02

Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer

Gastrointestinal

Stage IV Gastric Cancer With Metastasis

NCT03034850 2017-01-27

Thrombin Generation and Platelet Activation in CRS/HIPEC

GynecologicOther solid neoplasmThoracic

Mesothelioma, Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT01399190 2016-09-28

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

68 enrolled 8 charts

Gastrointestinal

Colorectal Neoplasms

NCT01442155 2016-07-07

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

74 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

NCT01311050 2011-12-13

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

Gastrointestinal

Colorectal Neoplasms